Funding for this research was provided by:
Received: 13 April 2020
Accepted: 20 November 2020
First Online: 1 December 2020
Ethics approval and consent to participate
: The institutional ethics committee approved of pseudonymised data collection and anonymised analysis and the requirement for individual patient consent was waived as this study was based on observational data from quality assurance and routine clinical care (Protocol Number PV4685).
: Not applicable.
: SB has received lecture honoraria from Gettinge and Xenios. SK is a member of the advisory board of Xenios and has received consulting fees or lecture honoraria and travel costs from Xenios, ArjoHuntleigh, Baxter, Fresenius, Novalung, and Sorin. DW has received lecture honoraria from AstraZeneca, Bayer, and Novartis. All other authors have declared no conflicts of interest to declare.